expresspharmaApril 06, 2020
Tag: Thermo Fisher Scientific , COVID-19 , diagnostic test , Vaccine
Thermo Fisher Scientific announced that it is accelerating its efforts with diagnostic testing and vaccine development technologies to effectively manage COVID-19 outbreak in the country. The company has has received Emergency Use Authorization (EUA) by the US Food and Drug Administration for its TaqPathCOVID-19 Combo Kit for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swab, nasopharyngeal aspirate, and bronchoalveolar lavage (BAL).The company also received the CE mark in the European Union (EU) for its diagnostic test to detect COVID-19.
In India, Thermo Fisher is working closely with the relevant government organizations as well as private testing laboratories to support scale up of testing. Thermo Fisher has been supplying reagents and other personal protective equipments to several government approved testing laboratories across the country. These tests are performed on Real Time PCR instruments and can be conducted on other supplier instruments. The company has ramped up its efforts to produce these reagents and is well-positioned to cater to the growing requirement of conducting more tests as situation evolves.
The move comes in synchronization with utilizing Thermo Fisher’s Applied Biosystems Taq Path assay designed to provide patient results within four hours of a sample being received by a laboratory. The estimated time-to-result includes time for sample preparation and analysis. In addition to receiving the designated approvals in the U.S. and E.U., Thermo Fisher’s diagnostic test has received the designated approvals in India, Canada, Singapore, Australia and New Zealand.
"Thermo Fisher Scientific in India is geared to support COVID-19 testing initiatives to ensure priority access to instruments, consumables, safety supplies and other products to rapidly and efficiently respond to the outbreak. We are carefully managing our inventory, production and supply chains to ensure we continue to manufacture and deliver the products and services our customers rely on. It is times like these that reinforce our commitment to our mission which is to enable our customers to make the world healthier, cleaner and safer", said Amit Chopra, Managing Director, India and Middle East, Thermo Fisher Scientific.
Register as Visitor to CPhI China 2020!
-----------------------------------------------------------------------
Editor's Note:
En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,
for any copyright disputes involved in the articles,
please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: